dioscin has been researched along with Colitis-Associated Cancer in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Luo, H; Lv, Z; Wang, B; Wang, X; Wang, Z; Wu, X; Xun, J; Yang, L; Yu, X; Zhang, A; Zhang, L; Zhang, Q; Zhou, S | 1 |
1 other study(ies) available for dioscin and Colitis-Associated Cancer
| Article | Year |
|---|---|
Dioscin modulates macrophages polarization and MDSCs differentiation to inhibit tumorigenesis of colitis-associated colorectal cancer.
Topics: Animals; Carcinogenesis; Cell Differentiation; Colitis; Colitis-Associated Neoplasms; Dextran Sulfate; Disease Models, Animal; Inflammation; Macrophages; Mice; Mice, Inbred C57BL; Myeloid-Derived Suppressor Cells | 2023 |